Medical/Pharmaceuticals
Thailand BOI Approves Investment Worth USD1.54 billion in Biochemicals, Data Centers, and Hospital; Sets New Promotion Category for the Repair of Used EV Batteries and ESS
BANGKOK, June 14, 2024 /PRNewswire/ -- The Thailand Board of Investment (BOI) today approved the investment promotion applications of eight large projects worth a combined56.95 billion baht (USD 1.54 billion), including a bio-ethylene plant project by the local joint venture ofBrazil's Braskem, a...
2024-06-14 15:28
2985
Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.
HANGZHOU, China, June 14, 2024 /PRNewswire/ -- Venus Medtech (02500. HK), a leading provider of integrated solutions for transcatheter structural heart valvular therapies inChina, announced today that its in-house developed innovative transcatheter pulmonic valve replacement (TPVR) system, Venus...
2024-06-14 15:15
2279
Innovent Delivers Oral Presentation on Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Advanced Non-small Cell Lung Cancer and Other Solid Tumors at the 2024 ESMO Virtual Plenary
SAN FRANCISCO and SUZHOU, China, June 14, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology ...
2024-06-14 08:34
4926
Ethypharm expands its Mesalazine (Etiasa®) Portfolio in China
SAINT-CLOUD, France, June 13, 2024 /PRNewswire/ -- Ethypharm is pleased to announce the acquisition of a suppository form of Mesalazine by its Chinese affiliate, Shanghai Ethypharm Pharmaceuticals Ltd, from the Chinese Company Jiangsu Anbison Pharmaceutical. Leader in essential medicines for cen...
2024-06-13 22:33
2098
Sirnaomics Demonstrates Strong Antitumor Activity of Its Novel Oligonucleotide-ChemoDrug Conjugate in Journal of Oncology Research and Therapy
HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 13, 2024 /PRNewswire/ -- Sirnaomics Ltd.(the "Company"; together with its subsidiaries, "Sirnaomics" or the "Group"; stock code: 2257), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced that th...
2024-06-13 18:03
2775
NSG BioLabs and Eppendorf Group Sign Partnership to Support Biotech Companies in Singapore
* Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the startups have achieved nearlyUS$400 million funding in total alongside significant business milestones * The Eppendorf Group has signed a partnership agr...
2024-06-13 10:00
3143
Innovent Receives Fast Track Designation from the U.S. FDA for IBI343 (TOPO1i anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer
SAN FRANCISCO and SUZHOU, China, June 13, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune...
2024-06-13 08:00
4148
Amplify Healthcare Documentation: New AI-Powered Clinical Workflow Solution Incorporating Dragon Medical Capabilities
LONDON, June 13, 2024 /PRNewswire/ -- Prescribe Digital, a pioneering leader in healthcare technology, proudly introduces its AI-powered clinical documentation workflow solution, designed to elevate the efficiency of healthcare professionals grappling with the ever-increasing demands of accurate ...
2024-06-13 08:00
2533
Aesthetic procedures close to 35 million in 2023
Total surgical and non-surgical procedures increased by 3.4% in 2023, up to 34.9 million. MOUNT ROYAL, N.J., June 13, 2024 /PRNewswire/ -- The International Society of Aesthetic Plastic Surgery (ISAPS) released the results of its annual Global Survey on Aesthetic/Cosmetic Procedures this week a...
2024-06-13 05:00
1863
Ansell Recognized with the Frost & Sullivan 2024 Global Company of the Year Award for Revolutionizing Workplace Safety and Promoting Sustainability
Ansell is committed to ensuring the safety and well-being of workers worldwide with an extensive range of safety solutions that meet the specific needs of clinicians and healthcare providers. SAN ANTONIO, June 12, 2024 /PRNewswire/ -- Frost & Sullivan recently researched and conducted a review o...
2024-06-12 21:00
1610
Latest Updates of Viva Biotech's Portfolio Companies
HONG KONG, June 12, 2024 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the suc...
2024-06-12 19:51
2118
Growth market USA: Exyte plans to create up to 1,000 new jobs in high-tech facility industry
* Exyte to create up to 1,000 jobs in target industries across the USA to facilitate growth * Further expansion of service and production network in the USA * With official opening of new office in Boise, Idaho, Exyte expands to the Northwest * Exyte CEO Büchele: "Given its high market pot...
2024-06-12 19:13
1611
Innovent to Present Multiple Clinical Study Results of Mazdutide at the ADA's 84th Scientific Sessions
SAN FRANCISCO and SUZHOU, China, June 12, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...
2024-06-12 08:00
2730
Last patient in: Laminar Pharmaceuticals S.A. completes recruitment for CLINGLIO, the phase 2b/3 Clinical Trial of idroxioleic acid (LAM561) in combination with RT and TMZ for adults with newly diagnosed glioblastoma
140 patients have been recruited at sites in Spain, Italy, France and United Kingdom. The open readout of the trial is expected by late 2024. Laminar aims to submit regulatory filings or conditional marketing authorization by early 2025. PALMA DE MALLORCA, Spain, June 12, 2024 /PRNewswire/ -- Lam...
2024-06-12 02:15
1972
Blackmores' Launch of Nutriventia's TurmXTRA™ Based Range Validates Science of Concentrated Turmeric Ingredient
Blackmores' introduction of a range of products containing Nutriventia's TurmXTRA™ validates its science, safety, and efficacy MUMBAI, India, June 11, 2024 /PRNewswire/ -- Nutriventia Limited, a leading innovator of clinically proven, tech-driven clean ingredients for the health and wellness ind...
2024-06-11 20:00
1593
Chengdu's influence being felt across the world
CHENGDU, China, June 11, 2024 /PRNewswire/ -- Openness is a defining characteristic of contemporaryChina. In recent years, Chengdu, capital of Sichuan province, has used its location as a key hub in the Belt and Road Initiative and as a starting point of the ancient Southern Silk Road. By deepen...
2024-06-11 16:44
10181
Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with SDH-Deficient GIST Approved by the China CDE
SUZHOU, China, and ROCKVILLE, Md., June 11, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the Center for Drug Evaluation (CDE) ofChina'...
2024-06-11 11:25
2931
Element Six and Orbray partner to deliver the world's highest quality wafer-scale single crystal synthetic diamond
GRESHAM, Ore. and TOKYO, June 11, 2024 /PRNewswire/ -- Element Six
2024-06-11 08:00
3329
Octapharma's continuing dedication to improving the lives of people with rare bleeding disorders to be showcased at ISTH 2024
* Octapharma to present new clinical and scientific findings for wilate® and Nuwiq® at the upcoming ISTH 2024 Congress * New data and clinical study developments to be showcased in seven oral presentations, two posters and two Supported Symposia LACHEN, Switzerland, June 10, 2024 /PRNewswire/...
2024-06-10 21:09
2157
India Breakthrough: Bio Regenerative Precision Medicine Seminar Held in Hyderabad
HYDERABAD, India, June 10, 2024 /PRNewswire/ -- The Bio Regenerative Precision Medicine Seminar, held fromMay 18-20, 2024, at Le Méridien in Hyderabad, was a watershed moment inIndia's cell treatment journey. Prof. Dr Mike Chan, Chairman and Founder of European Wellness Biomedical Group (EWBG)...
2024-06-10 15:40
1903
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5214
